article · Frontiers in Medicine
This study provides a comprehensive clinicopathologic and immunophenotypic profile of EC in a Kenyan population. The predominance of endometrioid carcinoma and the frequent loss of MMR proteins in this subgroup align with global trends. However, the high proportion of p53-abnormal tumors, particularly among serous carcinomas, suggests a significant presence of biologically aggressive disease. These findings highlight the utility of IHC as a practical and informative tool for subtype classification and risk stratification in resource-limited settings.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.3389/fmed.2025.1607693
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
